Summary of all Market Analysis Prior Share Recommendations

This Summary prepared: January 2024

As "Market Analysis" has been published since 1981, this Summary is split by decades -
1991 to 1989:
80 recommendations showing an average Gain of +86.7% over an average of 2.5 years = 34.5% per annum.
1990 to 1999:
54 recommendations showing an average Gain of +284.3% over an average of 8.2 years = 34.8% per annum.
2000 to 2009:
51 recommendations showing an average Gain of +220.1% over an average of 8.9 years = 24.7% per annum.
2010 to 2019:
22 recommendations showing an average Gain of +7.2% over an average of 6.5 years = 1.1% per annum.
2020 to present:
8 recommendations showing an average Gain of +7.2% over an average of 6.5 years = 1.1% per annum.
Total from 1981 to the present:
215 recommendations showing an average Gain of +159.7% over an average of 5.8 years = 27.3% per annum.

Share Recommendations

	Buy Recommendation		Sell Recommendation		Dividends	Recent	%
Company	Date	Price	Date	Price	Rec'd	Price	Gain
2010 Our portfolio gains just 4.2% for the year - at least outperforming the market. We bought Ammtec for long term growth in January, but it was taken over by Campbell Brothers, realising a 73% gain. Finbar Group and CSG were bought for growth and Nomad Building Solutions as a recovery situation.
~Ammtec Ltd	11-01-10	257	13-11-06	418	27.5		+73
~Finbar Group	12-04-10	106			88.5	69	+49
~Onterran (Nomad Buildings)	16-08-10	103*	08-08-19	Nil	Nil		-100
~CSG Ltd	11-10-10	166*	10-02-20	31	60.5		-45

2011 Our portfolio dips 6.5% in value. Markets remain volatile. We buy Customers (as an undervalued situation - but it is taken over a year later), Novarise for growth and Penrice Soda as a high risk recovery situation.
~Customers Ltd	11-07-11	83	16-07-12	127	4.0		+58
~Novarise Renewable	14-03-11	25	16-04-18	Nil	Nil		-100
~Penrice Soda	11-07-11	17	12-05-14	Nil	Nil		-100

2012 The markets remain volatile - with a big dip in the June quarter - but ends the year ahead. Many of our shares are volatile, with a mix of gains and losses for the year, but overall the portfolio manages a very good 24.2% gain.
~Brickworks Ltd	12-11-12	1115			548.5	2715	+193

2013 For the year, TFS Corporation is up 199% and Prophecy up 127%, lifting our portfolio to an excellent 21.5% gain.
~Ausenco Ltd	10-06-13	191*	05-09-16	40	1.8		-78
~CardieX Ltd	11-11-13	150			Nil	13.5	-91

2014 The portfolio dips 9.8%.
~Acrux Ltd	12-05-14	99			14.0	5.1	-81
~Mt Gibson Iron	10-11-14	44			14.0	53	+52

2015 The ASX index fell -8.4% but our portfolio rose +29.5%. Technology One and Prophecy International became 10-baggers in November 2015 (but Prophecy fell back slightly at year end). Prophecy ended up +278.8% for the year, Opthea (Circadian) up +212.9% and Ellex Medical up +172.7%. We made no new buys or sells (except Chandler Macleod was taken over) as we are happy with the portfolio, so why change it?

2016 Our portfolio rises +14.9%, the ASX +14.6%. M2 Telecommunications merges with Vocus Communications in January and in August we sell to realise a 47-fold gain over 10 years.
~McMillan Shakespeare	07-11-16	1041			540.3	1586	+104
~OZ Minerals	14-03-16	522	10-04-23	2814	138.0		+466
~Reckon Limited (+1/3 GETB)	08-08-16	141			85.5	62	+36

2017 Our portfolio rises just +5.5%.
~Cynata Therapeutics	13-03-17	50			Nil	12.5	-75
~FBR Ltd	07-07-17	14			Nil	2.9	-79
~SIV Capital	13-11-17	740	08-03-21	33	40.0		-90

2018 Cynata Therapuetics doubles, but Noverise and Quintis are written-off. The portfolio falls -23.6%.

2019 Opthea Ltd rises strongly, but Onterran is written-off. The portfolio gains +15.6%.
~Woodside Energy	08-04-19	3410			869.7	3134	+17
~St Barbara	12-08-19	396			54.2	19.5	-81
~Energy Transition	11-11-19	11			Nil	4.3	-61
~Elixir Energy	07-12-19	4.2			Nil	8.8	+110

* Recommendation Prices Adjusted for Splits, Bonus and Cash Issues.